112 related articles for article (PubMed ID: 3374659)
1. [Prevention of HLA alloimmunization due to platelet transfusion].
van Marwijk Kooy M; Brand A; Sintnicolaas K; van Prooijen HC
Ned Tijdschr Geneeskd; 1988 Apr; 132(17):758-61. PubMed ID: 3374659
[No Abstract] [Full Text] [Related]
2. Prevention of HLA alloimmunization: role of leukocyte depletion and UV-B irradiation.
Snyder EL
Yale J Biol Med; 1990; 63(5):419-27. PubMed ID: 2293501
[TBL] [Abstract][Full Text] [Related]
3. Platelet transfusion therapy: platelet concentrate preparation and storage.
Lee VS; Tarassenko L; Bellhouse BJ
J Lab Clin Med; 1988 Apr; 111(4):371-83. PubMed ID: 3280712
[No Abstract] [Full Text] [Related]
4. Transfusion strategy: use of HLA-matched platelet transfusions for alloimmunized patients.
Menitove JE; Duquesnoy RJ
Am J Med Technol; 1981 Feb; 47(2):114-20. PubMed ID: 7223758
[TBL] [Abstract][Full Text] [Related]
5. The transfusion of HLA-matched platelets to thrombocytopenic patients resistant to random donor platelets.
Levy L; Woodfield DG
N Z Med J; 1984 Oct; 97(766):719-21. PubMed ID: 6595558
[TBL] [Abstract][Full Text] [Related]
6. Testing only donors with a prior history of pregnancy or transfusion is a logical and cost-effective transfusion-related acute lung injury prevention strategy.
Powers A; Stowell CP; Dzik WH; Saidman SL; Lee H; Makar RS
Transfusion; 2008 Dec; 48(12):2549-58. PubMed ID: 18717778
[TBL] [Abstract][Full Text] [Related]
7. [Prevention of platelet transfusion refractoriness and HLA alloimmunization by leukocyte filtered platelet transfusion: a meta analysis].
Yuan Q; Chen X; Cheng L; Zhou CH; Fu XM; Li YP; Wang NH; Wang L
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2011 Aug; 33(4):412-20. PubMed ID: 21906451
[TBL] [Abstract][Full Text] [Related]
8. [Transfusion of platelet concentrates].
Rieux C; Lee K; Lavaud A; Bierling P
Ann Med Interne (Paris); 1999 Dec; 150(8):631-41. PubMed ID: 10686645
[TBL] [Abstract][Full Text] [Related]
9. Prevention of platelet refractoriness due to HLA antibodies by administration of leukocyte-poor blood components.
Eernisse JG; Brand A
Exp Hematol; 1981 Jan; 9(1):77-83. PubMed ID: 7238644
[TBL] [Abstract][Full Text] [Related]
10. HLA alloimmunization with leukocyte concentrates from HLA-matched and HLA-non-matched donors in patients with Hunter's syndrome.
Kakaiya RM; Greenstein R; Pisciotto P; Slocum SK; Rosen D; Cable RG; Morse EE; Gainey A
Ann Clin Lab Sci; 1985; 15(5):435-40. PubMed ID: 3933403
[TBL] [Abstract][Full Text] [Related]
11. [Platelet alloimmunization in patients with oncologic blood disorders treated with multiple transfusions: prospective study in adults and children].
Pereira J; Bronfman L; Bertín P; Marzouka E; Hidalgo P; Amaya S; Mezzano D
Rev Med Chil; 1997 Nov; 125(11):1305-12. PubMed ID: 9609051
[TBL] [Abstract][Full Text] [Related]
12. [Optimal donor selection and the effectiveness of platelet transfusion in cases refractory to platelet transfusion].
Iwanaga T; Tsubaki K; Horiuchi A; Fujikawa Y; Kanemitsu Y
Rinsho Ketsueki; 1986 Jul; 27(7):1274-7. PubMed ID: 3784009
[No Abstract] [Full Text] [Related]
13. Bleeding risk and platelet transfusion refractoriness in patients with acute myelogenous leukemia who undergo autologous stem cell transplantation.
Toor AA; Choo SY; Little JA
Bone Marrow Transplant; 2000 Aug; 26(3):315-20. PubMed ID: 10967572
[TBL] [Abstract][Full Text] [Related]
14. Earlier detection of HLA alloimmunization in platelet transfusion refractoriness by flow cytometric analysis.
Sato S; Sakurai T; Yamamoto Y; Maekawa I; Ikeda H
Transfusion; 2005 Aug; 45(8):1399-401. PubMed ID: 16078932
[No Abstract] [Full Text] [Related]
15. Alloimmunization to public HLA antigens in multi-transfused platelet recipients.
MacPherson BR; Hammond PB; Maniscalco CA
Ann Clin Lab Sci; 1986; 16(1):38-44. PubMed ID: 3947028
[TBL] [Abstract][Full Text] [Related]
16. Component therapy.
Schmidt PJ
Int Anesthesiol Clin; 1982; 20(4):23-43. PubMed ID: 6816740
[No Abstract] [Full Text] [Related]
17. Efficacy of matched platelet transfusions from unrelated donors.
Radvany R; Green D; Rossi EC; Draugelis AK; Kahan BD
Transplant Proc; 1977 Mar; 9(1):513-7. PubMed ID: 867499
[No Abstract] [Full Text] [Related]
18. [The need of a registry of HLA-phenotyped platelet donors].
Castro Izaguirre E; Muncunill Ribas J
Med Clin (Barc); 1995 Nov; 105(18):696-9. PubMed ID: 8538251
[No Abstract] [Full Text] [Related]
19. [HLA compatibility and transfusion of a platelet concentrate--a necessary prerequisite for the successful transfusion of platelet concentrates in patients with HLA antibodies].
Májský A; Korínková P; Vítek A
Cas Lek Cesk; 1986 Mar; 125(12):363-5. PubMed ID: 3955595
[No Abstract] [Full Text] [Related]
20. [Antibody formation after filtered blood cell replacement in hematologic-oncologic patients].
Barz D; Staack D; Lehmann R; Stange K; Schnurstein K
Beitr Infusionsther Transfusionsmed; 1996; 33():30-4. PubMed ID: 8974705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]